Securities Code: 300871 Securities Abbreviation: Huishang Biology Announcement No.: 2026-019
Wuhan Huishang Biological Technology Co., Ltd. Resolution Announcement of the Fifth Meeting of the Fourth Board of Directors
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Convening of the Board Meeting
The fifth meeting of the fourth Board of Directors of Wuhan Huishang Biological Technology Co., Ltd. (hereinafter referred to as the "Company") was held in the Company's conference room on March 31, 2026, in person. The notice for this meeting was sent to all directors via email and telephone on March 28, 2026. There were 5 directors expected to attend, and 5 directors actually attended. The meeting was presided over by Chairman Mr. Zhang Weiyuan. Senior management personnel of the Company attended the meeting. The convocation, holding, and voting procedures of the meeting comply with relevant laws, administrative regulations, departmental rules, normative documents, and the "Articles of Association" of the Company.
II. Deliberation of the Board Meeting
After careful deliberation by the attending directors, the following proposals were approved:
(I) Deliberation and Approval of the "Proposal on Extending the Validity Period of the Resolution of the 2024 Annual Shareholders' Meeting for Issuing A Shares to Specific Objects"